Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors

Clinical trial NCT05145907 · UNKNOWN

Trial details

NCT number: NCT05145907
Sponsor: TJ Biopharma Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-negative Breast Cancer Head and Neck Squamous Cell Carcinoma

Start date: 2021-12-22
Primary completion: 2024-06-30
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.